SeqOne
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
73 150 6,651Activities
Technologies
Entity types
Location
22 Rue Durand, 34000 Montpellier, France
Montpellier
France
Employees
Scale: 51-200
Estimated: 87
Engaged corporates
14
6 8Added in Motherbase
5 years, 4 months ago
biotech Value proposition
From Genome to Personalized Medicine
Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
Precision Medicine, Genetics, Genomics, NGS, Bioinformatics, Transcriptomics, Epigenomics, Companion Diagnostics, IVD, and CE IVDROriginal language
From Genome to Personalized Medicine
Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases.
SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies.
By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all.
The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
Home - SeqOne
The most advanced platform for clinical genomic analysis: don't miss a mutation, increase your team’s productivity, meet quality and compliance goals, keep your data safe and accessible
https://seqone.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 8 Dec 2022 | | |
 Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Capitalistic Partnership Not event 30 Jun 2021 5 Feb 2024 | | |
 BIC de Montpellier Government Administration | BIC de Montpellier Government Administration | Other 26 Jan 2021 9 Jul 2024 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Capitalistic Partnership Not event 24 Jan 2022 | | |